news
Gold nanoparticles raise hopes for cancer treatments
Researchers have discovered properties of the precious metal that allow catalytic abilities to be accessed in living things without any side effects...
List view / Grid view
Cancer
news
Non-invasive technique for probing cells may reveal disease
Engineers have devised a non-invasive way to assess a cell's mechanical properties simply by observation...
news
Biopharma stages a strong recovery
After the first half of 2017 biopharma investors are in a position to be exuberant, the threat of US price controls that have overshadowed the sector for a year have largely disappeared...
news
BIOCAD does its sums for growth
Russian biotech company BIOCAD plans to leverage competitive advantages to take 5% of the European medicines market
news
Patients at risk as UK plans to leave Euratom
The UK's proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk...
news
UK trails behind EU in cancer diagnosis & treatment
A new report shows that the UK is trailing behind the rest of Europe in the diagnosis and treatment of cancer.
article
Microfluidic techniques for cancer therapies
Perhaps the most significant challenge in all of medicine is the need for more effective treatments for cancer, which causes one of every four deaths in the United States and bears a direct cost to our healthcare system of close to $100bn annually.
news
ESMO welcomes the adoption of the 2017 WHO Cancer Resolution
2 June 2017 | By Niamh Marriott, Junior Editor
ESMO welcomes the adoption of cancer resolution on prevention and control in the context of an integrated approach during the 70th World Health Assembly...
news
More needs to be done in cancer prevention and detection suggests report
19 May 2017 | By Sarah Wills, Editorial Assistant: European Pharmaceutical Review
While there have been improvements in some areas of cancer prevention and early detection, the use of potentially lifesaving measures is suboptimal and strongly influenced by individual behaviours, as well as social, economic, and public policy factors, according to a new report from the American Cancer Society.
news
Developing nanopreparation properties for use in anticancer medicines
15 March 2017 | By Steve Bremer, Managing Editor
Tumour therapy, particularly in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA to down-regulate the production...
article
Biosimilars create opportunities for sustainable cancer care
22 February 2017 | By Professor Josep Tabernero, Chair of the ESMO Cancer Medicines Working Group
Dr Josep Tabernero explains the benefits of biosimilars, showing how they can create sustainable, safe and affordable access to medicine globally...
news
Dolomite Bio’s Single Cell RNA-Seq System accelerating cancer research
8 December 2016 | By Dolomite Bio
Researchers at The Institute of Cancer Research (ICR), London, are taking advantage of the single cell encapsulation capabilities of Dolomite Bio’s Single Cell RNA-Seq System to investigate resistance mechanisms in prostate cancer...
news
Sophia Genetics’ data-driven technology gives actionable cancer information
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The new data-driven tech, OncoPortal, improves the diagnosis and treatment of solid tumours and haematological malignancies for patients around the world...
news
Predosing NHL patients with lilotomab before betalutin therapy lowers haematological toxicity
5 September 2016 | By Niamh Louise Marriott, Digital Content Producer
RM radiation doses were significantly higher in the patients who did not receive predosing, indicating that pre-dosing with lilotomab has a protective...
news
New England Biolabs® launches NEBNext Direct™ Technology with Cancer HotSpot Panel
8 August 2016 | By New England Biolabs, Inc.
Novel target enrichment technology, compatible with low input amounts from challenging sample types, uses a one-day workflow...
